[The risk/benefit ratio of low-dose cyclosporin in the treatment of severe rheumatoid arthritis]
{{output}}
Although the efficacy of cyclosporine therapy in rheumatoid arthritis has been established, there have been no long term studies of the risk/benefit ratio of cyclosporine A in severe rheumatoid arthritis. A prospective, open-label one-year study included 106 p... ...